Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(11); doi: 10.25236/FMSR.2022.041107.

Progress in Traditional Chinese Medicine Syndrome Differentiation and Treatment of Premature Ovarian Failure

Author(s)

Li Yi1, Xiaoping Cui1, Gege Li1, Mingzhu Huang1, Juanjuan Zhang1, Xinchun Xiao2, Xia Liu2

Corresponding Author:
Xiaoping Cui
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang City, 712046, China

2Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang City, 712046, China

Abstract

Premature ovarian failure has directly or indirectly caused unspeakable physical and mental suffering to many women because of its increasing incidence. People of all ethnic groups in the world are actively seeking the best method, but the results are only basically satisfactory. As far as treatment is concerned, Chinese and Western medical treatments have their own advantages and disadvantages. However, because of the variety of syndrome types in traditional Chinese medicine, there are many descriptions of a single disease syndrome, and there are few systematic generalizations and classifications. Therefore, the experience of traditional chinese medicine in the treatment of premature ovarian failure in recent 10 years is classified and summarized. Traditional chinese medicine believes that the root cause of premature ovarian failure is the disorder of viscera, and the pathological sign is phlegm dampness and blood stasis. Therefore, the treatment should be based on kidney, syndrome differentiation and treatment of multiple viscera, taking into account phlegm dampness and blood stasis, combined with periodic therapy and acupuncture treatment, striving to nourish the kidney, regulate the heart, liver, spleen and lungs, and smooth phlegm dampness and blood stasis, so as to achieve the effect of prevention and treatment.  

Keywords

Premature ovarian failure, Syndrome differentiation and treatment, Traditional Chinese medicine syndrome type, Traditional Chinese medicine treatment, Syndrome and treatment ideas

Cite This Paper

Li Yi, Xiaoping Cui, Gege Li, Mingzhu Huang, Juanjuan Zhang, Xinchun Xiao, Xia Liu. Progress in Traditional Chinese Medicine Syndrome Differentiation and Treatment of Premature Ovarian Failure. Frontiers in Medical Science Research (2022) Vol. 4, Issue 11: 38-46. https://doi.org/10.25236/FMSR.2022.041107.

References

[1] Xu FH, Hou YN, Ge PL, Chen HZ and Zhu SL. Characteristics of Chinese medicine treatment for premature ovarian failure [J]. J Liaoning Univ Tradit Chin Med, 2020, 22(01): 25-28.

[2] Cao WW, Zhao Y and Feng XL. Advances in Chinese and Western medicine research on premature ovarian failure [J]. J Tradit Chin Med, 2020, 35(01): 81-85.

[3] Fu YJ, Gao JJ, Li QY, Ming WJ and Qin JJ. Exploring the role of bone marrow mesenchymal stem cells in the treatment of premature ovarian failure based on the kidney tonic method [J]. Chin J Integr Med, 2021, 41(07): 860-864.

[4] Chen J and Wang CY. Professor Hu Guohua's experience in the treatment of premature ovarian failure and low ovarian reserve function [J]. J Integr Tradit Chin West Med, 2013, 8(10): 988-990.

[5] Duan FY, Li Q, Liu L and Zhai M. Advances in the diagnosis and treatment of premature ovarian failure[J]. Chin Med Sci J, 2016, 6(07): 38-42+66.

[6] Li J, Xu L and Gao Y. Progress and status of research on the etiological mechanism and treatment of premature ovarian failure [J]. Chin Med Sci J, 2021, 11(02): 58-61.

[7] Zheng N, Cui XP, Ma R, Li ZA and Xiao XC. On the Influence of Emotion on Ovarian Reserve Function and Discussion on Diagnosis and Treatment. Int J Clin Exp Med, 2021, 5(1), 89–95.

[8] Duan FY, Li Q, Liu L and Zhai M. Advances in the diagnosis and treatment of premature ovarian failure [J]. Chin Med Sci J, 2016, 6(07): 38-42+66.

[9] Liu TY, Wu XH and Liu BX. Chinese medicine treatment of premature ovarian failure [J]. J Gynecol Endocrinol, 2020, 7(24): 53-54.

[10] Wang YS and Zhang LM. Advances in Chinese medicine research on premature ovarian failure [J]. J Qiannan Nat Med Coll, 2019, 32(02): 100-103.

[11]  Li QN. Study on the clustering analysis of Chinese medical evidence types and the relationship with psychosocial factors in premature ovarian failure [D]. Chengdu Univ Tradit Chin Med, 2018.

[12] Li ZA, Cui XP, Ma R, Zheng N and Xiao XC. Research progress in the taxonomy of evidence of premature ovarian failure [J]. J Changchun Univ Tradit Chin Med, 2021, 37(04): 920-923.

[13] Fu YJ, Gao JJ, Li QY, Ming WJ and Qin JJ. Exploring the role of bone marrow mesenchymal stem cells in the treatment of premature ovarian failure based on the kidney tonic method [J]. Chin J Integr Med, 2021, 41(07): 860-864.

[14] Wang H and Bai SF. Clinical study of tonifying kidney and regulating menstruation soup combined with estrogen and progestin replacement for premature ovarian failure[J]. J Tradit Chin Med, 2020, 42(10): 960-963.

[15] Lu XN, Xu XR and Lin LJ. Clinical observation on the treatment of premature ovarian failure by tonifying kidney Erxian Tang [J]. Chin J Integr Med, 2008(07): 594-596.

[16] Cui Q, Ji ZQ and Feng Q. Efficacy of warming the kidney and helping Yang, benefiting Qi and nourishing Blood with manual cycle therapy in the treatment of premature ovarian failure due to kidney Yang deficiency[J]. Chin J Integr Med, 2013, 33(12): 1642-1644.

[17] Wu LT, Shi Y, Liu YF and Yang QW. Xiao Chengxi's experience in the treatment of premature ovarian failure [J]. J Tradit Chin Med, 2017, 58(02): 108-110.

[18] Qian YY. Effects of Qizi Yi Kidney Li Chong Tang on ovarian reserve function and the regulatory role of miR-29a [D]. Beijing Univ Tradit Chin Med, 2018.

[19] Zhu L, Luo SP. Luo Songping's treatment of premature ovarian failure from the theory of yin and yang [J]. Chin J Bas Chin Med, 2020, 26(06): 841-843.

[20] Lv XL, Gao J, Zhou YX, Tian H and Luo SP. Luo Songping's experience in treating infertility with decreased ovarian reserve function [J]. J Tradit Chin Med, 2020, 61(13): 1139-1141.

[21] Luo YX, Li B, Li XR and Ma YB. Exploration of the treatment of premature ovarian failure from the spleen theory [J]. Modern Dist Edu Chin Med, 2021, 19(06): 50-52.

[22] Wan YH. An analysis of Professor Zhang Yuzhen's experience in the treatment of premature ovarian failure [J]. Lishizhen Med Mater Med Res, 2014, 25(07): 1721-1722.

[23] Chen JX, Liu Q, Kou MJ, Liu YY, Liu Y and Wang XX. The theory and prescription view of Chinese medicine in the treatment of premature ovarian failure from the liver [J]. Chin J Tradit Chin Med, 2014, 29(06): 1916-1919.

[24] Han YH, Geng TT and Han YG. Experience of Han's gynecology in the treatment of premature ovarian failure based on the theory of "liver and kidney"[J].  Chi J Tradit Chin Med, 2021, 36(12): 7177-7179.

[25] Du CY, Chai HJ and Zou ZJ. Clinical observation of 40 cases of premature ovarian failure treated with tonifying kidney and nourishing liver soup [J]. New Chin Med, 2009, 41(10): 49-50+8.

[26] Fang XH and Xia GC. Exploring the efficacy of Qingxinzhi Kidney Tang as an adjunct to Western medicine in the treatment of premature ovarian failure [J]. Chin J Exp Formulary, 2016, 22(09): 158-161.

[27] Hu RK and Tan Y. Exploring the experience of Xia Guicheng, a national medical master, in regulating premature ovarian failure [J]. Jiangsu Tradit Chin Med, 2015, 47(05): 1-4.

[28] Zhang Y, Tan Y and Xia GC. Xia Guicheng's experience in tonifying the heart and nourishing the kidney for premature ovarian failure [J]. J Guangzhou Univ Tradit Chin Med, 2015, 32(05): 934-936.

[29] Tong Q. Chai Songyan's experience in the treatment of premature ovarian failure [J]. Beijing Tradit Chin Med, 2009, 28(03): 196-197.

[30] Teng XX. Chai Songyan's experience in the treatment of premature ovarian failure by discriminating evidence [J]. Chin J Tradit Chin Med, 2011, 18(11): 92-93+107.

[31] Sun MN and Han YH. Summary of Professor Han Yanhua's experience in treating premature ovarian failure with kidney deficiency and blood stasis [J]. Chin Med Herald, 2020, 17(01): 142-145.

[32] Yang KF, Chen Z, Cheng SW, Liu HP, Li L, Zhou H, Deng GM and Xiao XQ. Research progress on the mechanism of chemotherapy-derived premature ovarian failure and its prevention and treatment by Chinese medicine [J]. J Hunan Univ of Tradit Chin Med, 2022, 42(02): 332-336.

[33] Zhang WY, Liu HP, You ZL, Huang SS, Zhang SM, Long HL and Zhang CJ. You Zhaoling's experience in treating premature ovarian failure from the theory of deficiency and stasis [J]. Chin J Tradit Chin Med, 2020, 35(07): 3440-3443.

[34] Zhang B and Liu JX. Clinical research and treatment progress of premature ovarian failure in Chinese and Western medicine [J]. J Modern Tradit and West Med, 2020, 29(32): 3643-3648.

[35] Jin L. Clinical study on the treatment of phlegm-damp internal obstruction type of premature ovarian failure by adding warm bile soup [D]. Hunan Univ Tradit Chin Med, 2010.

[36] Wen DT, Li XM, Zhang Q, Liu ZQ, Zhou HP, Wang SY, Cao LX and Xu M. Prof. Li Liyun's clinical reflections on the treatment of infertility with reduced ovarian reserve function in Chinese medicine [J]. Lishizhen Med Mater Med Res, 2015, 26(01): 211-213.

[37] Hu XD and Li LY. Professor Li Liyun's experience in the treatment of premature ovarian failure [J]. New Chin Med, 2010, 42(07): 127-128.

[38] Liu LJ, Wang GQ and Xia T. Clinical experience of Director Xia Tian's three-step therapy for premature ovarian failure [J]. New Chin Med, 2014, 46(03): 32-34.

[39] Chen GS. Experience of Dr. Ye Yiping, chief physician, in the diagnosis and treatment of premature ovarian failure [J]. Modern Dist Edu Chin Med, 2020, 18(19): 50-52.

[40] Teng XX, Li HT,Tong Q and Yao HY. Research on data mining of Chinese herbal prescriptions for the treatment of premature ovarian failure by Chai Songyan's discernment [J]. Chin J Tradit Chin Med, 2015, 30(10): 3709-3712.

[41] Dong L, Jiang L, Lin XQ, Meng W and Zhu NS. Effects of kidney tonification and blood activation formula on serum FSH, LH, E2 and PRL in patients with premature ovarian failure [J]. Shanghai J Tradit Chin Med, 2007(11): 48-49.

[42] Cai LR, Li DJ, Sun XX and Wang MY. Study on the prevention and treatment of experimental premature ovarian failure in mice with the formula of tonifying kidney and activating blood[J]. J Integr Tradit Chin West Med, 2001(02): 126-129.

[43] Li CY and You ZL. Professor You Zhaoling's experience in the treatment of premature ovarian failure [J]. Hunan J Tradit Chin Med, 2012, 28(03): 18-20.

[44] Chen XF. Identification and treatment of 22 cases of premature ovarian failure [J]. Sichuan J Tradit Chin Med, 2000(01): 35-36.

[45] Li YJ and Jiang HZ. Jiang Huizhong's experience in the treatment of premature ovarian failure [J]. Hubei J Tradit Chin Med, 2006(06): 28-29.

[46] Zhao HY. Observation on the efficacy of sequential cycle therapy with Chinese medicine in the treatment of premature ovarian failure [J]. Sichuan J Tradit Chin Med, 2007(05): 83-84.

[47] Wu JL, Shi WM and Xia QQ. Clinical study of Cai's cycle therapy for premature ovarian failure [J]. Lishizhen Med Mater Med Res, 2020, 31(05): 1165-1166.

[48] Zhou RX and Liu SY. Clinical study of hormone replacement artificial cycle herbal therapy for premature ovarian failure [J]. China &Foreign Medical Treatment, 2015, 34(27): 20-22.

[49] Xia LJ and Xia YB. Progress of clinical research and mechanism of action of acupuncture in the treatment of premature ovarian failure in the past 20 years [J]. Chin Acupunct, 2018, 38(05): 565-570.

[50] Luo X, Li Q, Cheng J, Hua QX, Xie ZY, Yang PY and Xia YB. A systematic review and Meta-analysis of the effectiveness of acupuncture in the treatment of premature ovarian failure [J]. J Tradit Chin Med, 2016, 57(12): 1027-1032.

[51] Xu DH, Luo YH, Shao Y, Wang Z, Fang G, Wei Y and Yan PY. Research progress on the clinical efficacy of acupuncture in the treatment of premature ovarian failure [J]. Med Review, 2021, 27(22): 4543-4547.

[52] Huang FF, Lu QB. Research on Chinese medicine treatment of premature ovarian failure [J]. Chin J Bas Chin Med, 2015, 21(03): 372-374.